Genomics Science & Emerging Technologies, Science Research & Evidence Directorate, Department of Health
Policy Fellow Alum, Centre for Science and Policy
Mark Bale leads on a number of emerging healthcare science areas and their ethical, legal and policy implications. He is also Deputy Chief Scientific Adviser and Head of Profession for Scientists and Engineers for the Department of Health.
His current priorities are delivery of the 100,000 Genomes (seconded to Genomics England) together with regenerative medicine and gene therapy, genome editing, precision medicine and rare disease policy. He also represents the UK on bioethics, genomics, and biotechnology at international committees. He was Chair of the Committee on Bioethics at the Council of Europe from 2014-2016.
Mark has a research background in microbial genetics and joined the Department of Health in 1999 after working on the occupational safety of GMOs and pathogens.